Mendus to participate in upcoming conferences in April 2023 and to hold investor call following Annual Report publication on April 17th
Mendus AB (“Mendus” publ; IMMU.ST), a biopharmaceutical company focused on immunotherapies addressing tumor recurrence, today announced its participation in the...